Literature DB >> 20740090

SERVE Ethiopia.

Philip J Tuso1.   

Abstract

Entities:  

Year:  2009        PMID： 20740090      PMCID： PMC2911814          DOI： 10.7812/TPP/08-082

Source DB:  PubMed          Journal:  Perm J        ISSN： 1552-5767


× No keyword cloud information.
  4 in total

1.  ESRD patients in 2001: global overview of patients, treatment modalities and development trends.

Authors:  Stefan Moeller; Simona Gioberge; Gail Brown
Journal:  Nephrol Dial Transplant       Date:  2002-12       Impact factor: 5.992

Review 2.  How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example.

Authors:  Jean-Marie Krzesinski; Kiswaya Ernest Sumaili; Eric Cohen
Journal:  Nephrol Dial Transplant       Date:  2006-10-11       Impact factor: 5.992

Review 3.  End-stage renal disease in sub-Saharan and South Africa.

Authors:  Saraladevi Naicker
Journal:  Kidney Int Suppl       Date:  2003-02       Impact factor: 10.545

4.  How can we achieve global equity in provision of renal replacement therapy?

Authors:  Sarah L White; Steven J Chadban; Stephen Jan; Jeremy R Chapman; Alan Cass
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408
  4 in total
  3 in total

Review 1.  Nephrology in Africa--not yet uhuru.

Authors:  Charles R Swanepoel; Nicola Wearne; Ikechi G Okpechi
Journal:  Nat Rev Nephrol       Date:  2013-08-20       Impact factor: 28.314

2.  The Lived Experience of Primary Family Caregivers of Patients on Hemodialysis Treatment in Southern Ethiopia: A Phenomenological Study.

Authors:  Amene Abebe; Aseb Arba; Kebreab Paulos; Wogayehu Abera; Temesgen Sidamo; Shimelis Shiferaw; Zinabu Abraham; Daniel Baza; Banchialem Nega; Selamawit Woldeyohannes
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-02-22

3.  Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study.

Authors:  Belayneh Kefale; Yewondwossen Tadesse; Minyahil Alebachew; Ephrem Engidawork
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.